|
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement |
Abbott DE, Merkow RP, Cantor SB, Fleming JB, Varadhachary GR, Crane C, Bentrem DJ, Bilimoria KY |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Abbott DE, Merkow RP, Cantor SB, Fleming JB, Varadhachary GR, Crane C, Bentrem DJ, Bilimoria KY. Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement. Annals of Surgical Oncology 2012; 19(12): 3659-3667 Indexing Status Subject indexing assigned by NLM MeSH Adenocarcinoma /economics /mortality /therapy; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Cost-Benefit Analysis; Decision Support Techniques; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms /economics /mortality /therapy; Prognosis; Prospective Studies; Quality-Adjusted Life Years; Survival Rate; Young Adult AccessionNumber 22012041075 Date bibliographic record published 22/01/2013 |
|
|
|